Author

S. Fournier

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biochemistry· 1 Plant Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:genetic perturbation / CRISPR· 2 Organism:human· 2 Assay:metabolomics· 2 Organism:C. elegans· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

A. Roulston· 2 shared A. Veloso· 2 shared C. Bernier· 2 shared M. Zinda· 2 shared A. Alvarez-Quilon· 1 shared A. Bonneau Fortin· 1 shared A. Maciuk· 1 shared A. Singhania· 1 shared

Activity by Year

2020-2021 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Roulston

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Guiding ATR and PARP inhibitor combinations with chemogenomic screens

M. Zimmermann, C. Bernier, B. Kaiser, S. Fournier, L. Li, J. Desjardin, A. Skeldon, V. Rimkunkas, A. Veloso, J. T. Young, A. Roulston, M. Zinda

This study identifies genetic alterations that enhance the efficacy of ATR and PARP inhibitor combinations while reducing toxicity through CRISPR screens and mechanistic analysis.

bioRxiv · Dec 13, 2021Cancer Biology

Cannabinoids vs. whole metabolome: relevance of cannabinomics in analyzing Cannabis varieties

P. Vasquez-Ocmin, G. Marti, M. Bonhomme, F. Mathis, S. Fournier, S. Bertani, A. Maciuk

This paper introduces cannabinomics, a workflow combining metabolome analysis and statistics to differentiate Cannabis sativa varieties, showing it identifies minor compounds as key markers.

bioRxiv · Jun 7, 2021Biochemistry

CCNE1 amplification is synthetic-lethal with PKMYT1 kinase inhibition

D. Gallo, J. T. F. Young, J. Fourtounis, G. Martino, A. Alvarez-Quilon, C. Bernier, N. M. Duffy, R. Papp, A. Roulston, R. Stocco, J. Szychowski, A. Veloso, H. Alam, P. S. Baruah, A. Bonneau Fortin, , D. Durocher

The paper identifies PKMYT1 as a therapeutic target for CCNE1-amplified cancers, showing that its inhibition leads to synthetic lethality and tumor regression in combination with gemcitabine.

bioRxiv · Apr 8, 2021Cancer Biology

Phytohormone production by the arbuscular mycorrhizal fungus Rhizophagus irregularis

S. Pons, S. Fournier, C. Chervin, G. Becard, S. Rochange, N. Frei-dit-frey, V. Puech-pages

This study identifies phytohormones produced by the arbuscular mycorrhizal fungus Rhizophagus irregularis using mass spectrometry and gas chromatography.

bioRxiv · Jun 11, 2020Plant Biology